Lucia Altucci

Lucia Altucci's AcademicInfluence.com Rankings

Lucia Altucci

Philosophy

#9264

World Rank

#12798

Historical Rank

Logic

#6249

World Rank

#7750

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Lucia Altucci's Degrees

Doctorate Medicine University of Naples Federico II
PhD Pathology University of Naples Federico II

Why Is Lucia Altucci Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lucia Altucci's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (3106)
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 (2014) (799)
The promise of retinoids to fight against cancer (2001) (752)
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells (2005) (591)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway (2005) (529)
RAR and RXR modulation in cancer and metabolic disease (2007) (475)
Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. (2013) (404)
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery (2016) (360)
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. (1996) (356)
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL (2001) (349)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (323)
BLUEPRINT to decode the epigenetic signature written in blood (2012) (320)
Cancer epigenetics: Moving forward (2018) (289)
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. (2010) (272)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect (2009) (263)
Trials with ‘epigenetic’ drugs: An update (2012) (240)
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment (2008) (230)
Sirtuin functions and modulation: from chemistry to the clinic (2016) (229)
Design of selective nuclear receptor modulators: RAR and RXR as a case study (2007) (200)
Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. (2009) (198)
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. (2005) (182)
ERRATUM: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway (2005) (174)
Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G1 by Inducing Transcriptional Derepression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene Promoter (2004) (164)
Sirtuins and Disease: The Road Ahead (2012) (160)
Nuclear receptors in cell life and death (2001) (134)
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes (2009) (133)
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. (2009) (133)
epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors. (2008) (129)
Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties. (2006) (123)
RAR‐independent RXR signaling induces t(15;17) leukemia cell maturation (1999) (117)
Histone Deacetylase Inhibition with Valproic Acid Downregulates Osteocalcin Gene Expression in Human Dental Pulp Stem Cells and Osteoblasts: Evidence for HDAC2 Involvement (2014) (117)
Molecular networks in Network Medicine: Development and applications (2020) (115)
Retinoids: potential in cancer prevention and therapy (2004) (114)
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. (2013) (113)
Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells (2005) (113)
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence (2009) (112)
Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. (2005) (108)
ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. (2012) (108)
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities. (2014) (102)
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart (2011) (100)
Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells (2008) (98)
Targeting Histone Deacetylases in Diseases: Where Are We? (2015) (98)
Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases. (2008) (97)
Histone acetyltransferase inhibitors and preclinical studies (2009) (97)
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities. (2007) (96)
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype (2019) (93)
SIRT1 Activation by Natural Phytochemicals: An Overview (2020) (90)
A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. (2004) (90)
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer (2016) (87)
in human breast cancer cells (2008) (87)
UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression (2012) (85)
Endocannabinoid control of sperm motility: the role of epididymus. (2007) (84)
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin (2020) (80)
Antiproliferative, Antibacterial and Antifungal Activity of the Lichen Xanthoria parietina and Its Secondary Metabolite Parietin (2015) (79)
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. (2014) (77)
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells. (2012) (77)
Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus. (1997) (76)
Laccase treatment impairs bisphenol A‐induced cancer cell proliferation affecting estrogen receptor α‐dependent rapid signals (2008) (76)
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome (2010) (75)
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1 (2012) (74)
Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. (2010) (74)
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity. (2017) (72)
A Gradient of 2-Arachidonoylglycerol Regulates Mouse Epididymal Sperm Cell Start-Up1 (2010) (72)
Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues (2012) (71)
Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues. (2010) (70)
17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation. (1996) (66)
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation (2010) (65)
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat (2016) (64)
Psidium guajava L. anti‐neoplastic effects: induction of apoptosis and cell differentiation (2012) (64)
Antioxidant, antimicrobial and anti-proliferative activities of Solanum tuberosum L. var. Vitelotte. (2013) (63)
HDAC modulation and cell death in the clinic. (2012) (63)
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases. (2009) (63)
Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia. (2012) (62)
Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. (2009) (61)
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation. (2010) (60)
Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. (2014) (58)
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2. (2008) (55)
Synthesis of Benzamides Related to Anacardic Acid and Their Histone Acetyltransferase (HAT) Inhibitory Activities (2008) (55)
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells (2018) (54)
Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors. (1996) (54)
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors (2007) (54)
SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor (2021) (53)
Retinoic-acid-induced apoptosis in leukemia cells. (2004) (53)
Epigenetic drugs against cancer: an evolving landscape (2014) (53)
HDAC inhibitors as epigenetic regulators for cancer immunotherapy. (2018) (53)
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium. (2020) (53)
Molecular identification of ERα‐positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes (2004) (52)
Nuclear receptor superfamily: Principles of signaling (2003) (51)
Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune Systems (2016) (51)
The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. (2016) (51)
Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. (2001) (50)
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells. (2016) (50)
Acute myeloid leukemia: therapeutic impact of epigenetic drugs. (2005) (49)
Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy (2019) (48)
Low 17beta-Estradiol Levels in Cnr1 Knock-Out Mice Affect Spermatid Chromatin Remodeling by Interfering with Chromatin Reorganization1 (2013) (48)
Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008 (2011) (47)
Epigenetic drugs: from chemistry via biology to medicine and back (2016) (47)
The Helicobacter pylori's protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells (2008) (45)
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues. (2011) (45)
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells (2006) (45)
Effect of bisphenol A with or without enzyme treatment on the proliferation and viability of MCF-7 cells. (2009) (45)
Epigenetic therapies in haematological malignancies: searching for true targets. (2009) (44)
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors. (2006) (44)
Evaluation of Histone Deacetylases as Drug Targets in Huntington’s Disease models (2010) (43)
Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities. (2012) (43)
miR-194-5p/BCLAF1 deregulation in AML tumorigenesis (2017) (43)
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues. (2010) (42)
Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma (2006) (42)
Identification of Tri‐ and Tetracyclic Pyrimidinediones as Sirtuin Inhibitors (2010) (42)
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. “Vitelotte” (2015) (41)
Histone deacetylase inhibitors: a patent review (2009 – 2011) (2013) (41)
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. (2014) (40)
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation (2017) (40)
Coexpression of Helicobacter pylori's proteins CagA and HspB induces cell proliferation in AGS gastric epithelial cells, independently from the bacterial infection. (2003) (40)
New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity. (2012) (39)
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b (2013) (39)
Novel benzofuran–chromone and –coumarin derivatives: synthesis and biological activity in K562 human leukemia cells (2013) (39)
Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells. (2001) (38)
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment (2019) (37)
Bispyridinium dienes: histone deacetylase inhibitors with selective activities. (2007) (37)
Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens. (1998) (37)
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors (2011) (36)
Breast Cancer Vaccines: New Insights (2017) (35)
Histone deacetylase inhibitors: recent insights from basic to clinical knowledge & patenting of anti-cancer actions. (2011) (34)
Epigenetic-based therapy: From single- to multi-target approaches. (2015) (33)
Natural compounds in epigenetics: a current view. (2014) (33)
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. (2014) (32)
Identification of Two New Synthetic Histone Deacetylase Inhibitors That Modulate Globin Gene Expression in Erythroid Cells from Healthy Donors and Patients with Thalassemia (2007) (32)
Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer. (2010) (32)
TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule. (2009) (31)
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies. (2018) (31)
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells (2009) (31)
D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts. (2016) (30)
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes (2019) (30)
Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs). (2011) (30)
The Jumonji family: past, present and future of histone demethylases in cancer (2014) (30)
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells. (2012) (30)
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells. (2012) (29)
Comparative Phytochemical Characterization, Genetic Profile, and Antiproliferative Activity of Polyphenol-Rich Extracts from Pigmented Tubers of Different Solanum tuberosum Varieties (2020) (29)
Impact of histone deacetylase inhibitors SAHA and MS‐275 on DNA repair pathways in human mesenchymal stem cells (2010) (29)
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile. (2011) (29)
Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO. (2009) (29)
Regulation of nuclear receptor and cofactor expression in breast cancer cell lines. (2003) (28)
“Stockpile” of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells (2016) (28)
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors (2008) (28)
Relationship between genome and epigenome - challenges and requirements for future research (2014) (28)
RIP1–HAT1–SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer (2018) (27)
Leukemia: beneficial actions of retinoids and rexinoids. (2004) (27)
Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells (2019) (27)
In vivo functional analysis of the mouse estrogen receptor gene promoter: a transgenic mouse model to study tissue-specific and developmental regulation of estrogen receptor gene transcription. (1995) (27)
Molecular Pathways: The Complexity of the Epigenome in Cancer and Recent Clinical Advances (2012) (26)
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias (2015) (26)
Combating Actions of Green 2D-Materials on Gram Positive and Negative Bacteria and Enveloped Viruses (2020) (26)
Nuclear size as estrogen-responsive chromatin quality parameter of mouse spermatozoa. (2013) (26)
Identification and characterization of PKF118-310 as a KDM4A inhibitor (2017) (26)
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 (2021) (25)
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition (2019) (25)
Quinoline‐Based p300 Histone Acetyltransferase Inhibitors with Pro‐apoptotic Activity in Human Leukemia U937 Cells (2014) (25)
New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations. (2009) (25)
The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion (2000) (25)
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer (2019) (24)
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape (2014) (24)
Sonoporation by microbubbles as gene therapy approach against liver cancer (2018) (24)
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells (2019) (24)
Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase (2018) (24)
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia (2018) (24)
Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells (2019) (23)
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. (2019) (23)
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents. (2019) (23)
Histone deacetylase inhibitors: clinical implications for hematological malignancies (2010) (22)
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathway (2019) (22)
Molecular Docking Simulations on Histone Deacetylases (HDAC)-1 and -2 to Investigate the Flavone Binding (2020) (22)
Identification of microRNA Expression Patterns in Cutaneous and Uveal Melanoma Cell Lines (2014) (22)
Novel uracil-based 2-aminoanilide and 2-aminoanilide-like derivatives: histone deacetylase inhibition and in-cell activities. (2008) (22)
The Two-Faced Role of SIRT6 in Cancer (2021) (21)
New Anacardic Acid‐Inspired Benzamides: Histone Lysine Acetyltransferase Activators (2010) (20)
Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells (2018) (20)
Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines (2013) (20)
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90 (2020) (20)
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia (2015) (20)
Retinoids and TRAIL: two cooperating actors to fight against cancer. (2004) (20)
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability (2008) (20)
Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. (2003) (20)
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence (2020) (19)
Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells. (2014) (19)
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells (2013) (19)
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside (2021) (19)
MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency. (2013) (19)
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells (2012) (19)
Outer Membrane Vesicles Derived from Klebsiella pneumoniae Are a Driving Force for Horizontal Gene Transfer (2021) (18)
Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies (2020) (18)
Outer Membrane Vesicles Derived from Klebsiella pneumoniae Influence the miRNA Expression Profile in Human Bronchial Epithelial BEAS-2B Cells (2020) (18)
Time for epigenetics. (2009) (18)
Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E2-treated Human T Cells* (2008) (18)
Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis (2017) (18)
Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27 kip1 expression by estrogen in rat endometrium (2001) (17)
Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders. (2019) (16)
tert‐Butylcarbamate‐Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells (2013) (16)
Novel Cinnamyl Hydroxyamides and 2‐Aminoanilides as Histone Deacetylase Inhibitors: Apoptotic Induction and Cytodifferentiation Activity (2011) (16)
Design, Synthesis, and Biological Evaluation of 2‐Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors (2012) (16)
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies. (2016) (16)
Secretome profiling of cytokines and growth factors reveals that neuro‐glial differentiation is associated with the down‐regulation of Chemokine Ligand 2 (MCP‐1/CCL2) in amniotic fluid derived‐mesenchymal progenitor cells (2016) (15)
TRAIL: At the Center of Drugable Anti-Tumor Pathways (2005) (15)
The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer (2021) (15)
Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. (2018) (14)
A global network for network medicine (2020) (14)
Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death (2018) (14)
miRNA-mediated deregulation in leukemia (2012) (14)
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells (2012) (14)
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring. (2013) (13)
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors. (2021) (13)
Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A (2018) (13)
Synthesis of 7-alkylidene-7,12-dihydroindolo[3,2-d]benzazepine-6-(5H)-ones (7-alkylidene-paullones) by N-cyclization-oxidative Heck cascade and characterization as sirtuin modulators. (2015) (13)
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia (2018) (13)
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’ (2020) (12)
Altered folate receptor 2 expression in uraemic patients on haemodialysis: implications for folate resistance. (2013) (12)
Recent insights into Histone Acetyltransferase-1: biological function and involvement in pathogenesis (2020) (12)
Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity. (2007) (12)
Decryption of the Retinoid Death Code in Leukemia (2002) (12)
Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies (2012) (12)
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation. (2020) (12)
Synthetic approaches to DNMT inhibitor SGI-1027 and effects on the U937 leukemia cell line. (2013) (12)
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin (2020) (12)
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy (2020) (12)
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity. (2014) (11)
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells (2019) (11)
Rexinoid-triggered differentiation and tumor-selective apoptosis of AML by protein kinase A-mediated de-subordination of RXR (2006) (11)
Glycation of Wild‐Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric Species (2015) (11)
HDAC2‐dependent miRNA signature in acute myeloid leukemia (2019) (11)
Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway (2020) (10)
Total synthesis of the proposed structures of the DNA methyl transferase inhibitors peyssonenynes, and structural revision of peyssonenyne B. (2011) (10)
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation. (2020) (10)
The KDM Inhibitor GSKJ4 Triggers CREB Downregulation via a Protein Kinase A and Proteasome-Dependent Mechanism in Human Acute Myeloid Leukemia Cells (2020) (10)
The Network Medicine Imperative and the Need for an International Network Medicine Consortium. (2020) (10)
Epigenetic mechanisms underlying prostate cancer radioresistance (2021) (10)
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients (2021) (10)
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer (2019) (10)
Gene Transactivation and Transrepression in MYC-Driven Cancers (2021) (10)
The Cannabinoid Receptor CB1 Stabilizes Sperm Chromatin Condensation Status During Epididymal Transit by Promoting Disulphide Bond Formation (2020) (10)
Novel N-hydroxybenzamide-based HDAC inhibitors with branched CAP group. (2009) (9)
Synthesis and Biological Evaluation of Tripartin, a Putative KDM4 Natural Product Inhibitor, and 1‐Dichloromethylinden‐1‐ol Analogues (2018) (9)
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses (2017) (9)
Highlighting chromosome loops in DNA-picked chromatin (DPC) (2011) (9)
Structure–Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase (2017) (9)
3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy (2018) (8)
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation (2022) (8)
The Role of Ozone Carried by Liposomes in the Therapy of Infectious and Skin-Regenerating Ocular Surface (2019) (8)
Pyrrole‐Based Hydroxamates and 2‐Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities (2009) (8)
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches (2021) (8)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect (2009) (8)
Fetal-Perinatal Exposure to Bisphenol-A Affects Quality of Spermatozoa in Adulthood Mouse (2020) (8)
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer (2021) (8)
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line (2020) (8)
Epigenetic multiple modulators. (2011) (8)
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome (2020) (7)
MicroRNA Expression Profiling Using Agilent One-Color Microarray. (2017) (7)
Identification of small molecules inhibitors of GCN5 histone acetyltransferase activity (2006) (7)
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs). (2020) (7)
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents. (2008) (7)
Combined HAT/EZH2 modulation leads to cancer-selective cell death (2018) (7)
Age-related miRNome landscape of cumulus oophorus cells during controlled ovarian stimulation protocols in IVF cycles (2021) (7)
Developing novel non-hydroxamate histone deacetylase inhibitors: the chelidamic warhead (2012) (6)
A key HDAC6 dependency of ARID1A-mutated ovarian cancer (2017) (6)
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options (2020) (6)
Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions (2021) (6)
Tumour cell population growth inhibition and cell death induction of functionalized 6‐aminoquinolone derivatives (2015) (6)
HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights (2021) (5)
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation (2018) (5)
Metabolite Profile and In Vitro Beneficial Effects of Black Garlic (Allium sativum L.) Polar Extract (2021) (5)
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation (2020) (5)
Up-regulation of miR-146b and down-regulation of miR-200b contribute to the cytotoxic effect of histone deacetylase inhibitors on ras-transformed thyroid cells. (2013) (5)
Cancer therapy: new drugs are emerging based on molecular targeting but still many challenges. (2007) (4)
Synthesis of 7‐Alkylidene‐7,12‐dihydroindolo[3,2‐d]benzazepine‐6‐(5H)‐ones (7‐Alkylidene‐paullones) by N‐Cyclization—Oxidative Heck Cascade and Characterization as Sirtuin Modulators. (2015) (4)
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway (2022) (4)
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group (2021) (4)
An innovative high frequency hyperthermia approach against SARS-CoV-2 and related virus: feasibility analysis (2021) (4)
Preclinical Development Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI 5008 (2011) (4)
Functions, aberrations, and advances for chromatin modulation in cancer. (2014) (4)
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response (2022) (4)
A DNA Methyltransferase Modulator Inspired by Peyssonenyne Natural Product Structures (2012) (4)
The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma (2021) (4)
Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement. (2001) (3)
Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1 (2001) (3)
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows (2022) (3)
Transcriptional Control of Cell Cycle Progression by Estrogenic Hormones: Regulation of Human Cyclin D1 Gene Promoter Activity by Estrogen Receptor-a (2001) (3)
(INVITED)Quantitative detection of SARS-CoV-2 virions in aqueous mediums by IoT optical fiber sensors (2021) (3)
SIRT1 inhibition affects angiogenic properties of human MSCs. (2014) (3)
Novel Pyridine‐Based Hydroxamates and 2′‐Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity (2020) (3)
MRI Radiomics in Prostate Cancer: A Reliability Study (2021) (3)
Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer Models (2021) (3)
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis (2014) (3)
Deregulation of Cell Death in Cancer: Recent Highlights (2020) (3)
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. (2014) (3)
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency (2022) (3)
Chemical Epigenetics (2020) (2)
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients (2022) (2)
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability. (2022) (2)
DNA Mutations via Chern–Simons Currents (2021) (2)
Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders (2019) (2)
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives. (2022) (2)
Topic 1 . 1 Nuclear receptor superfamily : Principles of signaling * (2003) (2)
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma? (2021) (2)
by Affecting Content of Transition Protein 2 mRNA and Histone Displacement Cannabinoid Receptor 1 Influences Chromatin Remodeling in Mouse Spermatids (2010) (2)
Discovery of novel tetrahydrobenzo[b]thiophene-3-carbonitriles as histone deacetylase inhibitors. (2021) (2)
Corrigendum to “SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs” (2015) (2)
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia (2022) (2)
I BET on anti‐FGFR to fight cancer resistance (2019) (2)
Epigenetics in Acute Myeloid Leukemia (2016) (2)
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol (2022) (1)
A combinatorial approach to gene expression analysis: DNA microarrays. (2005) (1)
Epigenetic Targets in Drug Discovery. Edited by Wolfgang Sippl and Manfred Jung. (2010) (1)
Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen resistant prostate cancer cell line (PC3) (2006) (1)
Levels of Nrf2 and Keap1 Are Associated with Poor Prognostic Features In Myelodysplastic Syndromes (MDS) (2010) (1)
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC‐MEF2 complexes (2020) (1)
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance. (2022) (1)
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity (2022) (1)
Apoptosis 2003 “From signaling pathways to therapeutic tools”, (2003) (1)
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine (2021) (1)
Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer (2018) (1)
Erratum: HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment (Proceedings of the National Academy of Sciences of the United States of America (2008) 105 (19183-19187) DOI: 10.1073/pnas.0805514105)) (2009) (1)
Epigenetics: Moving Forward (2019) (1)
Sonoporation by microbubbles as gene therapy approach for liver cancer (2016) (1)
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: evidence in human cardiomyocyte cell line. (2022) (1)
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy. (2022) (1)
MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance (2020) (1)
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions (2020) (1)
Relationship between genome and epigenome - challenges and requirements for future research (2014) (1)
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics (2022) (1)
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells (2020) (1)
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis. (2022) (0)
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma (2023) (0)
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway (2022) (0)
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells (2022) (0)
Dual HDAC–BRD4 inhibitors endowed with antitumor and antihyperalgesic activity (2022) (0)
Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells (2018) (0)
Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives (2023) (0)
Tubulin-6j complex (2018) (0)
Irreversible inhibition of TRF2TRFH recruiting functions: a strategy to induce telomeric replication stress in cancer cells (2023) (0)
763 ACTIVATION OF SIRT1 ATTENUATES VASCULAR DYSFUNCTION AND THROMBOSIS IN MTHFR DEFICIENCY (2022) (0)
Advances in Brief Estrogens Do Not Modify MAP Kinase-dependent Nuclear Signaling during Stimulation of Early G 1 Progression in Human Breast Cancer Cells 1 (2001) (0)
Correction for ‘‘Genome-wide expression profiling reveals distinct clusters of transcriptional regulation during bovine preimplantation development in vivo,’’ by W. A. Kues, S. Sud- (2009) (0)
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside (2021) (0)
Thank you to all of our reviewers in 2020 (2021) (0)
Effect of the Sirtuin Inhibitor MC2494 on RIPK1 Expression (2019) (0)
Abstract PL05-03: Molecular basis and novel options for alternative epigenetic treatments against cancer. (2011) (0)
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside (2021) (0)
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease". (2019) (0)
MicroRNA Expression Profiling Using Agilent One-Color Microarray. (2023) (0)
Single-Cell Photothermal Analysis Induced by MoS2 Nanoparticles by Raman Spectroscopy (2022) (0)
Author Correction: Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells (2020) (0)
Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase (2018) (0)
Sirtuin functions and modulation: from chemistry to the clinic (2016) (0)
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer. (2023) (0)
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A (2022) (0)
Design and Synthesis of Oligopeptidic Parvulin Inhibitors (2022) (0)
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells (2019) (0)
A genic and epigenetic combination therapy for liver cancer (2017) (0)
HIF3A Inhibition Triggers Browning of White Adipocytes via Metabolic Rewiring (2022) (0)
Estrogen Actions in Hormone-responsive Cancer Cells (2002) (0)
Histone demethylase inhibitors and their potential in cancer treatment (2020) (0)
Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023) (0)
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation (2022) (0)
Towards an epigenetic treatment of neoplastic disease (2011) (0)
266 UVI5008, a novel epigenetic enzyme inhibitor (2010) (0)
BARD1: a New Target In Leukemia (2010) (0)
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells (2018) (0)
NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase family (2022) (0)
Referee Acknowledgement for 2013 (2014) (0)
HAT1: Landscape of Biological Function and Role in Cancer (2023) (0)
1 Epigenetics : Moving Forward (2018) (0)
Identification of a New Functional HDAC Complex Composed by HDAC5, GATA1 and EKLF in Human Erythroid Cells (2012) (0)
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation (2022) (0)
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer (2023) (0)
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition (2019) (0)
Editorial: Sirtuinome Rewiring to Hijack Cancer Cell Behavior and Hamper Resistance to Anticancer Intervention (2020) (0)
Post-maturation apoptosis of retinoid-insensitive myeloid blast cells by rexinoid-PKA crosstalk. (2002) (0)
Does SARS-CoV-2 Vaccination Impact the Planned Anticancer Administration Schedule? A Single-Center Report (2022) (0)
Author Correction: Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells (2020) (0)
Transcriptional control of cell cycle progression by estrogen hormones: Regulation of cyclin D1 gene promoter activity by ER-alpha (2000) (0)
Overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. (2005) (0)
Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3) (2009) (0)
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation (2022) (0)
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets (2022) (0)
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path? (2022) (0)
Resource Distinct Trends of DNAMe thylation Patterning in the Innate and Adaptive Immune Systems Graphical Abstract Highlights (2016) (0)
Characterization and gene expression of cancer stem cells grown as sarcospheres from human primary sarcomas. (2011) (0)
Chromatin&Epigenetics@Milan meeting (2011) (0)
Cell Reports Resource Distinct Trends of DNAMethylation Patterning in the Innate and Adaptive Immune Systems (2017) (0)
THE MOLECULAR PATHWAYS AFFECTED BY THE AML ASSOCIATED ONCOFUSION PROTEINS AML1-ETO AND PML-RAR (2010) (0)
The impact of epigenetic landscape on ovarian cells in infertile older women undergoing IVF procedures (2023) (0)
Epigenetics Communications: where are we? (2021) (0)
Advanced Assays in Epigenetics (2019) (0)
Epigenome-based treatment against cancer (2019) (0)
Epigenetic drugs against cancer: an evolving landscape (2014) (0)
Epigenetic treatment of cancer: molecular basis (2009) (0)
Cover Picture: tert‐Butylcarbamate‐Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells (ChemMedChem 5/2013) (2013) (0)
Cover Picture: A DNA Methyltransferase Modulator Inspired by Peyssonenyne Natural Product Structures (ChemMedChem 12/2012) (2012) (0)
Correction for ‘ ‘ HDAC 2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment (2009) (0)
Ontogenic-Specific Increasesin HDAC1 Activity and Transcription Factor Association During the Maturation of Human Adult Erythroblasts in Vitro . (2009) (0)
Biochemical reaction network topology defines dose-dependent Drug-Drug interactions (2023) (0)
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma (2022) (0)
90 Regulation of cell life and death by retinoids (2003) (0)
Functional Validation of the Putative Oncogenic Activity of PLAU (2022) (0)
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection (2023) (0)
Epigenetic drugs: from chemistry via biology to medicine and back (2016) (0)
Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome (2011) (0)
Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability (2022) (0)
Estrogen actions in hormone-responsive cancer cells. J. Jap. Assoc. Gynecologic Oncol. Vol 20, 142-160 (2002) (0)
Retinoid and rexinoid induced apoptosis in leukaemia:towards novel option for therapy (2003) (0)
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses (2017) (0)
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells. (2022) (0)
Correction to: Exosomal MicroRNAs: Comprehensive Methods from Exosome Isolation to miRNA Extraction and Purity Analysis. (2023) (0)
Metabolite Proﬁle and In Vitro Beneﬁcial Effects of Black Garlic ( Allium sativum L.) Methanol Extract (2021) (0)
Molecular mechanisms of female sex hormone action on proliferation. (2005) (0)
The transcriptional and epigenetic targets of the AML associated oncofusion proteins AML1-ETO and PML-RAR alpha (2010) (0)
Epigenetic mechanisms underlying prostate cancer radioresistance (2021) (0)
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia (2022) (0)
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game? (2023) (0)
Abstract 10140: Lysine Acetylation Determines Dissociation From GAP-Junctions and Lateralization of Connexin 43 in Normal and Dystrophic Heart. (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lucia Altucci?

Lucia Altucci is affiliated with the following schools:

Università degli Studi della Campania Luigi Vanvitelli
University of Oxford
University of Vigo
University of Naples Federico II